Patent assignee · US · COMPANY

Abraxis BioScience, LLC

82Patents
79Active
82Granted
58Portfolio score

Filing activity: Dec 23, 2004 → Feb 14, 2024 · 30 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7820788B2 Compositions and methods of delivery of pharmacological agents Emerging Cross-Sectional Technologies 161 Active
US8138229B2 Compositions and methods of delivery of pharmacological agents Emerging Cross-Sectional Technologies 146 Active
US7923536B2 Compositions and methods of delivery of pharmacological agents Emerging Cross-Sectional Technologies 131 Active
US8314156B2 Compositions and methods of delivery of pharmacological agents Emerging Cross-Sectional Technologies 128 Active
US8034375B2 Combinations and modes of administration of therapeutic agents and combination therapy Human Necessities 125 Active
US7758891B2 Combinations and modes of administration of therapeutic agents and combination therapy Human Necessities 117 Active
US8735394B2 Combinations and modes of administration of therapeutic agents and combination therapy Human Necessities 114 Active
US8268348B2 Combinations and modes of administration of therapeutic agents and combination therapy Human Necessities 107 Active
US8034765B2 Compositions and methods for preparation of poorly water soluble drugs with increased stability Emerging Cross-Sectional Technologies 102 Active
US8853260B2 Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof Human Necessities 99 Active
US9101543B2 Combinations and modes of administration of therapeutic agents and combination therapy Human Necessities 90 Active
US7771751B2 Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents Emerging Cross-Sectional Technologies 62 Active
US7981445B2 Compositions and methods for preparation of poorly water soluble drugs with increased stability Emerging Cross-Sectional Technologies 58 Active
US8911786B2 Nanoparticle comprising rapamycin and albumin as anticancer agent Human Necessities 57 Active
US7780984B2 Methods and compositions for treating proliferative diseases Human Necessities 53 Active
US7858782B2 Triazine derivatives and their therapeutical applications Chemistry; Metallurgy 51 Active
US8257733B2 Methods and compositions for treating proliferative diseases Human Necessities 49 Active
US8846771B2 Compositions and methods of delivery of pharmacological agents Emerging Cross-Sectional Technologies 48 Active
US8137684B2 Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof Human Necessities 47 Active
US9149455B2 Methods of treating melanoma Human Necessities 42 Active
US9511046B2 Methods of treating pancreatic cancer Human Necessities 42 Active
US8927019B2 Methods and compositions for treating recurrent cancer Emerging Cross-Sectional Technologies 38 Active
US8999396B2 Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane Human Necessities 38 Active
US9061014B2 Intravascular delivery of nanoparticle compositions and uses thereof Human Necessities 37 Active
US9012519B2 Compositions and methods of delivery of pharmacological agents Emerging Cross-Sectional Technologies 36 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.